Compare EPOW & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EPOW | ICCM |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2M | 20.4M |
| IPO Year | 2019 | 2013 |
| Metric | EPOW | ICCM |
|---|---|---|
| Price | $0.67 | $5.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 129.1K | ★ 8.4M |
| Earning Date | 05-15-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $139.51 |
| Revenue Next Year | N/A | $75.66 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.53 | $0.13 |
| 52 Week High | $1.86 | $9.54 |
| Indicator | EPOW | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 60.56 | 56.84 |
| Support Level | $0.66 | $0.62 |
| Resistance Level | $0.74 | $5.69 |
| Average True Range (ATR) | 0.07 | 1.53 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 96.00 | 43.67 |
E Power Inc, through its subsidiaries, is engaged in the manufacturing and sale of graphite anode material for lithium-ion batteries. It operates a plant in Guizhou Province, China, powered by electricity from renewable sources, which contributes to the plant's low production costs and reduced environmental impact in the production of graphite anode materials. Additionally, the Group also operates a knowledge-sharing platform business. Its reportable operating segments are: Graphite anode business, which generates the maximum revenue, and Knowledge sharing and enterprise business. Substantially all of the Group's revenue is derived in the People's Republic of China (the PRC).
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.